-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Reneo Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q2 2024.
- Reneo Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.16 USD/shares, a 75.4% increase year-over-year.
- Reneo Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -1.68 USD/shares, a 28.2% increase year-over-year.
- Reneo Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -2.52 USD/shares, a 18.9% decline from 2022.
- Reneo Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -2.12 USD/shares, a 3.2% increase from 2021.
- Reneo Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -2.19 USD/shares, a 77.2% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)